Skip to main content

Table 5 One-way sensitivity analysis on the ICERs (as expressed in dollars per patient maintained in target range)

From: The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial

Test Selected variables Cost per patient maintained in target range
INR Base ICER Dominated*
  GP consultations - Upper 95% CI Dominated*
  GP consultations - Lower 95% CI Dominated*
  Hospital admissions - Upper 95% CI Dominated*
  Hospital admissions - Lower 95% CI SW Quadrant**
HbA1c Base ICER $40
  GP consultations - Upper 95% CI $1,049
  GP consultations - Lower 95% CI Dominant***
  Hospital admissions - Upper 95% CI $8,579
  Hospital admissions - Lower 95% CI Dominant***
ACR Base ICER Dominant***
  GP consultations - Upper 95% CI Dominant***
  GP consultations - Lower 95% CI Dominant***
  Hospital admissions - Upper 95% CI $17,647
  Hospital admissions - Lower 95% CI Dominant***
Lipids Base ICER $10,082
  GP consultations - Upper 95% CI $11,691
  GP consultations - Lower 95% CI $8,618
  Hospital admissions - Upper 95% CI $26,120
  Hospital admissions - Lower 95% CI Dominant***
  1. * Dominated: PoCT was more costly and less effective than laboratory testing
  2. ** SW Quadrant: PoCT was less costly and less effective than laboratory testing
  3. ***Dominant: PoCT was less costly and more effective than laboratory testing
  4. Note: this analysis was undertaken on all the other variables (consumables, tests, emergency department visits, specialist consultations and pharmaceuticals) but did not have an influence on the ICERs ie change the quadrant.